Khanfar MA - Search Results

1

Virtual Screening Identifies Inhibitors of SARS-CoV-2 Main Protease through Pharmacophore and Similarity Approaches.

Khanfar MA, Saleh M. Khanfar MA, et al. Curr Pharm Des. 2025 Jan 2. doi: 10.2174/0113816128358219241210101947. Online ahead of print. Curr Pharm Des. 2025. PMID: 39757683

2

SARS-CoV-2 Main Protease Inhibitors from Natural Product Repository as Therapeutic Candidates for the Treatment of Coronaviridae Infections.

Khanfar MA, Saleh MI. Khanfar MA, et al. Curr Med Chem. 2023 Nov 27. doi: 10.2174/0109298673271674231109052709. Online ahead of print. Curr Med Chem. 2023. PMID: 38013440

3

Discovery of natural-derived M^pro inhibitors as therapeutic candidates for COVID-19: Structure-based pharmacophore screening combined with QSAR analysis.

Khanfar MA, Salaas N, Abumostafa R. Khanfar MA, et al. Mol Inform. 2023 Apr;42(4):e2200198. doi: 10.1002/minf.202200198. Epub 2023 Feb 10. Mol Inform. 2023. PMID: 36762567

4

Structure-based Pharmacophore Screening Coupled with QSAR Analysis Identified Potent Natural-product-derived IRAK-4 Inhibitors.

Khanfar MA. Khanfar MA. Mol Inform. 2021 Dec;40(12):e2100025. doi: 10.1002/minf.202100025. Epub 2021 Aug 24. Mol Inform. 2021. PMID: 34427398

5

Reversible Small Molecule Inhibitors of MAO A and MAO B with Anilide Motifs.

Hagenow J, Hagenow S, Grau K, Khanfar M, Hefke L, Proschak E, Stark H. Hagenow J, et al. Drug Des Devel Ther. 2020 Jan 28;14:371-393. doi: 10.2147/DDDT.S236586. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32099324 Free PMC article.

6

Discovery of novel urokinase plasminogen activator (uPA) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis.

Al-Sha'er MA, Khanfar MA, Taha MO. Al-Sha'er MA, et al. Among authors: khanfar ma. J Mol Model. 2014 Jan;20(1):2080. doi: 10.1007/s00894-014-2080-4. Epub 2014 Jan 28. J Mol Model. 2014. PMID: 24469103

7

Unsupervised pharmacophore modeling combined with QSAR analyses revealed novel low micromolar SIRT2 inhibitors.

Khanfar MA, Taha MO. Khanfar MA, et al. J Mol Recognit. 2017 Sep;30(9). doi: 10.1002/jmr.2623. Epub 2017 Mar 15. J Mol Recognit. 2017. PMID: 28299833

8

Discovery of nanomolar phosphoinositide 3-kinase gamma (PI3Kγ) inhibitors using ligand-based modeling and virtual screening followed by in vitro analysis.

Taha MO, Al-Sha'er MA, Khanfar MA, Al-Nadaf AH. Taha MO, et al. Among authors: khanfar ma. Eur J Med Chem. 2014 Sep 12;84:454-65. doi: 10.1016/j.ejmech.2014.07.056. Epub 2014 Jul 18. Eur J Med Chem. 2014. PMID: 25050878

9

Combining docking-based comparative intermolecular contacts analysis and k-nearest neighbor correlation for the discovery of new check point kinase 1 inhibitors.

Jaradat NJ, Khanfar MA, Habash M, Taha MO. Jaradat NJ, et al. Among authors: khanfar ma. J Comput Aided Mol Des. 2015 Jun;29(6):561-81. doi: 10.1007/s10822-015-9848-1. Epub 2015 May 9. J Comput Aided Mol Des. 2015. PMID: 25956379

10

Pharmacophore modeling, homology modeling, and in silico screening reveal mammalian target of rapamycin inhibitory activities for sotalol, glyburide, metipranolol, sulfamethizole, glipizide, and pioglitazone.

Khanfar MA, AbuKhader MM, Alqtaishat S, Taha MO. Khanfar MA, et al. J Mol Graph Model. 2013 May;42:39-49. doi: 10.1016/j.jmgm.2013.02.009. Epub 2013 Mar 13. J Mol Graph Model. 2013. PMID: 23545333

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70 results

Search Page

Filters